paliperidone + trimethoprim

paliperidone + trimethoprim is a combination of two distinct pharmaceutical drugs: paliperidone, an atypical antipsychotic primarily used for schizophrenia and schizoaffective disorders, and trimethoprim, an antifolate antibiotic used primarily to treat bacterial infections such as urinary tract infections. This combination is not recognized as a marketed combination drug and there is no evidence of it being developed, approved, or widely used as a fixed-dose combination for any indication. Paliperidone acts mainly by antagonizing dopamine D2 and serotonin 5-HT2A receptors in the brain, while trimethoprim inhibits bacterial dihydrofolate reductase, interfering with bacterial folic acid synthesis. When co-administered, clinical studies indicate no clinically significant pharmacokinetic interaction between the two agents[1][5].